Protecting Access to Medicare Act

Signed into law on April 1, 2014, the Protecting Access to Medicare Act of 2014 (PAMA) includes the most extensive reform of the Medicare Clinical Laboratory Fee Schedule (CLFS) since it was established in 1984. Section 216 of PAMA creates a new Section 1834A of the Social Security Act, which contains many of the CLFS…

Signed into law on April 1, 2014, the Protecting Access to Medicare Act of 2014 (PAMA) includes the most extensive reform of the Medicare Clinical Laboratory Fee Schedule (CLFS) since it was established in 1984. Section 216 of PAMA creates a new Section 1834A of the Social Security Act, which contains many of the CLFS reforms. Starting on January 1, 2017, most rates on the CLFS will be derived from private payor rates for laboratory services. PAMA also designates certain tests as “advanced diagnostic laboratory tests” (ADLTs); includes provisions affecting coding, coverage and oversight of the CLFS; and makes some changes to CMS’s review of mis-valued codes in the Physician Fee Schedule (PFS) affecting anatomic pathology services provided by laboratories.

Click here for a summary of CLFS reform provisions in PAMA.

Read More

  • Letter from Industry Stakeholders in Response to GAO Report on PAMA

    February 21, 2019
    ...
  • Seniors managing diabetes are counting on Congress to protect their essential lab services

    February 11, 2019
    For America’s seniors, diabetes is now the number one health condition leading to frequent emergency room visits, according to a recent study in the Annals of Internal Medicine. On top of that staggering statistic, the CDC reports that one in four seniors has diabetes—the highest prevalence among any age group. Most patients know that disease monitoring and management requires reliable access to routine testing.Continue Reading »...
  • ACLA Statement on GAO Analysis & Medicare Lab Payments

    January 25, 2019
    Latest report reflects misleading, inaccurate assumptions on Medicare lab billing & payment  Washington, D.C. – Following the recent release of the Government Accountability Office’s (GAO) report on billing and reimbursement for clinical lab tests under the Medicare program, Julie Khani, President of the American Clinical Laboratory Association (ACLA), issued the following statement: “GAO’s conclusions on overbilling of laboratory services in the Medicare program are fundamentallyContinue Reading »...
  • For patients, PAMA reforms can’t wait

    January 22, 2019
    As we gaveled in a new Congress this month, protecting lab services for America’s seniors has never been more important. A recent piece in the Washington Post is the latest example of the value of essential lab services in early diagnosis and treatment of some of the most complex, serious health conditions facing patients – a critical element in our broader efforts to addressContinue Reading »...
  • ACLA Files Appeal in ACLA v. Azar, Asks U.S. Court of Appeals to Address HHS’s Overreach in Data Reporting

    December 04, 2018
    HHS’s continued flawed implementation of PAMA threatens beneficiaries’ access to critical lab services Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) advanced its case against the U.S. Department of Health and Human Services’ (HHS) flawed and harmful implementation of the Protecting Access to Medicare Act (PAMA). ACLA’s opening brief argues that HHS has exceeded its statutory authority, circumventing Congress’ stated directive ofContinue Reading »...
  • ACLA Appellant/Petitioner Brief: American Clinical Laboratory Association v. Alex Azar

    December 04, 2018
    ...
  • In a divided Washington, protecting seniors’ health care is an issue where everyone agrees

    December 03, 2018
    As lawmakers work to advance final legislative proposals, Congress has the chance to take decisive action on one issue that has bipartisan support: protecting seniors’ access to essential, life-saving lab services. Recognizing the critical role of routine testing for patient health and overall cost savings, more than 30 organizations representing patients, health care professionals, laboratories and diagnostic manufacturers are calling on Congress to takeContinue Reading »...
  • ACLA Statement on Final 2019 Medicare Payment Policies

    November 02, 2018
    Final rule takes preliminary steps to correct flawed data collection process; urgent Congressional action needed to protect millions of seniors from continued cuts to essential Medicare lab services   Washington, D.C. – Following the release of final Medicare payment policies, Julie Khani, President of the American Clinical Laboratory Association (ACLA) issued the following statement regarding new policy changes related to implementation of the Protecting AccessContinue Reading »...
  • PAMA Frequently Asked Questions (FAQs)

    October 26, 2018
    ...
  • ACLA Statement on Notice of Appeal in ACLA v. Azar

    October 19, 2018
    HHS’s continued reliance on faulty data collection process jeopardizes access to critical lab tests for millions of beneficiaries; ACLA files appeal following District Court decision  Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) filed its notice of appeal in its lawsuit against the U.S. Department of Health and Human Services (HHS) challenging its implementation of the Protecting Access to Medicare Act (PAMA),Continue Reading »...
1 2 3 4 5 6 7